102 assets in Soft Tissue Sarcoma

Therapeutic assets addressing Soft Tissue Sarcoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Pegfilgrastim Soft Tissue Sarcoma	University of California, Irvine	P1/2	CCC (48)
Spedox-6 Soft Tissue Sarcoma	University of California, Irvine	P1/2	CCC (48)
Talazoparib Soft Tissue Sarcoma	St. Jude Children's Research Hospital	P1/2	CCC (48)
gi-102 Soft Tissue Sarcoma	GI Innovation, Inc.	P1/2	CC (47)
Trastuzumab Deruxtecan Soft Tissue Sarcoma	GI Innovation, Inc.	P1/2	CC (47)
1.0% ip-001 for Soft Tissue Sarcoma	Immunophotonics, Inc.	P1/2	CC (45)
Catequentinib Soft Tissue Sarcoma	Sarcoma Oncology Research Center, LLC	P1/2	CC (45)
ilb2109 Soft Tissue Sarcoma	Innolake Biopharm	P1/2	CC (45)
mt-4561 Soft Tissue Sarcoma	Tanabe Pharma America, Inc.	P1/2	CC (45)
Tivozanib Soft Tissue Sarcoma	University of Florida	P1/2	CC (45)
Toripalimab Soft Tissue Sarcoma	Innolake Biopharm	P1/2	CC (45)
68ga-dfc413 Soft Tissue Sarcoma	Novartis Pharmaceuticals	P1	CC (43)
Immunoglobulin G1 [De-236-Glycine,267-Glutamic Acid,De-C-Terminal Lysine], Anti-(Human Tumor Necrosis Factor Receptor Tnfrsf9) (Human-Mus Musculus Monoclonal Lvgn6051 ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Lvgn6051 ?-Chain, Dimer Soft Tissue Sarcoma	M.D. Anderson Cancer Center	P1	CC (43)
Immunoglobulin G1 [De-236-Glycine,De-C-Terminal Lysine], Anti-(Human Cd40 Antigen) (Human Monoclonal Lvgn7409 ?1-Chain), Disulfide With Human Monoclonal Lvgn7409 ?-Chain, Dimer Soft Tissue Sarcoma	M.D. Anderson Cancer Center	P1	CC (43)
MDG1015 Soft Tissue Sarcoma	Medigene AG	P1	CC (43)
Pba-0405 Soft Tissue Sarcoma	Pure Biologics S.A.	Early P1	CC (43)
Pradusinstobart Soft Tissue Sarcoma	M.D. Anderson Cancer Center	P1	CC (43)
Son-1010 Soft Tissue Sarcoma	Sonnet BioTherapeutics	P1	CC (43)
177lu-dfc413 Soft Tissue Sarcoma	Novartis Pharmaceuticals	P1	CC (41)
68Ga-NNS309 Soft Tissue Sarcoma	Novartis Pharmaceuticals	P1	CC (41)
Autologous Total Tumor Mrna Loaded Dotap Liposome Vaccine Soft Tissue Sarcoma	University of Florida	P1	CC (41)
Ava-6000 (Fap-Activated Doxorubicin Prodrug) Soft Tissue Sarcoma	Avacta Life Sciences Ltd	P1	CC (41)
b7-h3 car t cells Soft Tissue Sarcoma	St. Jude Children's Research Hospital	P1	CC (41)
Cdx 1140 Soft Tissue Sarcoma	University of Southern California	P1	CC (41)
[Ga-68]-Pnt6555 Soft Tissue Sarcoma	POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company	P1	CC (41)
Immunoglobulin G1-Kappa, Anti-[Homo Sapiens Tnfrsf4 (Tumor Necrosis Factor Receptor (Tnfr) Superfamily Member 4, Ox40, Cd134)], Homo Sapiens Monoclonal Antibody Soft Tissue Sarcoma	HiFiBiO Therapeutics	P1	CC (41)
ln-144 Soft Tissue Sarcoma	Iovance Biotherapeutics, Inc.	P1	CC (41)
[Lu-177]-Pnt6555 Soft Tissue Sarcoma	POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company	P1	CC (41)
Modified Vaccinia Virus Ankara Vaccine Expressing P53 Soft Tissue Sarcoma	City of Hope Medical Center	P1	CC (41)
Pimitespib Soft Tissue Sarcoma	Brown University	P1	CC (41)
Recombinant Flt3 Ligand Soft Tissue Sarcoma	University of Southern California	P1	CC (41)
Second Generation 4-1Bbζ B7H3-Egfrt-Dhfr Soft Tissue Sarcoma	Seattle Children's Hospital	P1	CC (41)
Second Generation 4-1Bbζ Egfr806-Egfrt Soft Tissue Sarcoma	Seattle Children's Hospital	P1	CC (41)
Second Generation 4-1Bbζ Egfr806-Egfrt And A Second Generation 4 1Bbζ Cd19-Her2Tg Soft Tissue Sarcoma	Seattle Children's Hospital	P1	CC (41)
Sendegobresib Soft Tissue Sarcoma	C4 Therapeutics, Inc.	P1	CC (41)
Tocilizumab Soft Tissue Sarcoma	University of Southern California	P1	CC (41)
89zr-dfo-n-suc-c9scfv Soft Tissue Sarcoma	Var2 Pharmaceuticals	Early P1	C (39)
89Zr-DFO-N-Suc-F8scFv Soft Tissue Sarcoma	Var2 Pharmaceuticals	Early P1	C (39)
Alectinib Soft Tissue Sarcoma	OHSU Knight Cancer Institute	Early P1	C (39)
Alpelisib Soft Tissue Sarcoma	OHSU Knight Cancer Institute	Early P1	C (39)
Anastrozole Soft Tissue Sarcoma	OHSU Knight Cancer Institute	Early P1	C (39)
Cobimetinib Soft Tissue Sarcoma	OHSU Knight Cancer Institute	Early P1	C (39)
Entrectinib Soft Tissue Sarcoma	OHSU Knight Cancer Institute	Early P1	C (39)
Fulvestrant Soft Tissue Sarcoma	OHSU Knight Cancer Institute	Early P1	C (39)
Hyaluronidase Zzxf Soft Tissue Sarcoma	OHSU Knight Cancer Institute	Early P1	C (39)
Letrozole Soft Tissue Sarcoma	OHSU Knight Cancer Institute	Early P1	C (39)
Niraparib Soft Tissue Sarcoma	OHSU Knight Cancer Institute	Early P1	C (39)
Pba-0111 Soft Tissue Sarcoma	Pure Biologics S.A.	Early P1	C (39)
Pertuzumab Soft Tissue Sarcoma	OHSU Knight Cancer Institute	Early P1	C (39)
Trastuzumab Soft Tissue Sarcoma	OHSU Knight Cancer Institute	Early P1	C (39)

Showing 51 to 100 of 102 assets

PreviousPage 2 of 3Next